Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

DARA BioSciences Inc announces appointment of President, CEO and Executive Chairman


Tuesday, 17 Jun 2014 06:00am EDT 

DARA BioSciences Inc:Board of Directors has appointed Christopher G. Clement to President and Chief Executive Officer (CEO), effective immediately.David J. Drutz, M.D., Co's current CEO and Chief Medical Officer (CMO), will transition to Executive Chairman of Board of Directors while continuing to serve as CMO. 

Company Quote

44.25
0.12 +0.27%
16 Sep 2014